Epigenetics
13 results.
GRAND RAPIDS, Mich. (Oct. 21, 2024) — Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has been elected to the
MEMPHIS, Tenn. (Oct. 10, 2024) — Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but…
Collaboration, innovation and robust science are a powerful combination, one that drives discoveries aimed at improving health for generations to come. The era of siloed…
GRAND RAPIDS, Mich. (Nov. 15, 2023) — Van Andel Institute scientists Peter A. Jones, Ph.D., D.Sc. (hon), Russell Jones, Ph.D., and Peter W.…
GRAND RAPIDS, Mich. (September 28, 2023) — Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has received a seven-year, nearly…
Since October 2014, the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team has supported and launched breakthrough clinical trials that explore potential new…
GRAND RAPIDS, Mich. (Nov. 16, 2021) — Van Andel Institute scientists Patrik Brundin, M.D., Ph.D., Peter A. Jones, Ph.D., D.Sc. (hon), Russell Jones,…
Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…